Stem Cells: a discovery tool and a potential therapeutic modality

What should be taken into consideration using stem cell technologies in the pharmaceutical industry? How can you ensure a close fit with external collaborators? An interview of B2Bioworld with Jonathan Knowles, Member of the Roche Executive Committee and Head of Group Research.Reading time: 2 minRead more ...

Other articles recommended

B2Bioworld offers you background information

Managers of Disease Meet Masters of Personal Health

Stem Cells – Failings and Deliveries

Thinking Further About Stem Cells - Viewed from Systems Biology

Leroy Hood, President Institute for Systems Biology, Seattle, Washington (US)

Personalised Medicine: Let’s be clear what it means

Jonathan K.C. Knowles, at the time Head of Group Research Roche about his motivations, work in Roche, and competitors

Strategic ambiguities with "stem cells"

Bernd Kirschbaum,Global Discovery and Early Development Merck Serono on strategic ambiguities in technology development